Sign in

CIK 0000939767

  • Large accelerated filer

EXELIXIS, INC.

Sign in to watch
Ticker
EXEL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Jan 1
Incorporated
DE
Entity type
Operating
EIN
043257395
Phone
+1 650-837-7000
Business address
1851 HARBOR BAY PARKWAY, ALAMEDA, CA, 94502
Former names
EXELIXIS INC
  1. 4 Open-market sale EVP, Commercial sold 30,553 shares at $20.67 ($631,531)
  2. 4 Planned sale EVP, General Counsel & Sec sold 55,710 shares at $19.63 ($1,093,587)
  3. 4 Grant or award Director acquired 18,176 shares (grant or award)
  4. 4 Grant or award Director acquired 18,176 shares (grant or award)
  5. 3 Insider Initial Statement of Ownership
  6. 3 Insider Initial Statement of Ownership
  7. 4 Derivatives Options or other derivatives
  8. 4 Grant or award Director acquired 20,718 shares (grant or award)
  9. 4 Grant or award Director acquired 20,718 shares (grant or award)
  10. 4 Grant or award Director acquired 20,718 shares (grant or award)
  11. 4 Grant or award Director acquired 20,718 shares (grant or award)
  12. 4 Grant or award Director acquired 20,718 shares (grant or award)
  13. 4 Derivatives Options or other derivatives
  14. 4 Grant or award Director acquired 18,176 shares (grant or award)
  15. 3 Insider Initial Statement of Ownership
  16. 4 Shares withheld for taxes EVP, General Counsel & Sec gave up 11,967 shares (to pay taxes)
  17. 4 Shares withheld for taxes EVP and CFO gave up 18,446 shares (to pay taxes)
  18. 4 Shares withheld for taxes President and CEO gave up 33,518 shares (to pay taxes)
  19. 4 Shares withheld for taxes CSO/EVP Disc & Trans Research gave up 10,488 shares (to pay taxes)
  20. 4 Shares withheld for taxes EVP, Commercial gave up 18,065 shares (to pay taxes)

Page 11 of 73 · 1,458 filings